• 国家药监局综合司 国家卫生健康委办公厅
  • 国家药监局综合司 国家卫生健康委办公厅

[title missed]

Corresponding author: wang manxia, wmx322@aliyun.com
DOI: 10.12201/bmr.202410.00068
Statement: This article is a preprint and has not been peer-reviewed. It reports new research that has yet to be evaluated and so should not be used to guide clinical practice.
  •  

    Abstract: Myasthenia gravis(MG) is an autoimmune disease that primarily involves muscle weakness of the skeletal muscles (diaphragm, extraocular muscles) and myasthenic crises. MG is B cell-mediated and is associated with antibodies in the postsynaptic membrane of the neuromuscular junction against acetylcholine receptor(AChR),muscle-specific kinase(MuSK), lipoprotein-associated protein 4(LRP4),or agrin. Treatment options for MG management have expanded to include corticosteroids(GC), azathioprine(AZAZ), plasma exchange, etc. Unfortunately, a small number of MG cases do not respond to conventional treatment modalities. Tacrolimus(FK-506), a widely used immunosuppressant in recent years, has recently attracted interest due to its efficacy in the MG patient population.The purpose of this review was to demonstrate the efficacy of FK-506 monotherapy for MG and the factors that influence efficacy, using a limited review of databases including PubMed and Google Scholar. The results showed that FK-506 monotherapy was effectiv

    Key words: Myasthenia gravis; Tacrolimus; against acetylcholine receptor; corticosteroids; therapy.

    Submit time: 28 October 2024

    Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
  • 图表

  • wangazhen, lixinag, shijingyu, yetao, wuyuanhua. Gillan - the barre syndrome complicated by myasthenia gravis in 1 case. 2024. doi: 10.12201/bmr.202408.00038

    TANG Kan-kai, LIU Feng-qi, CHEN Zhi-dong. Effects of α7 nicotinic acetylcholine receptor agonist on intestinal injury and mitochondrial autophagy in sepsis mice. 2024. doi: 10.12201/bmr.202410.00066

    ChenYu, libowen, yangjinhua, liuyang, weiyunwei. Research progress and prospect of targeted therapy of microflora in hepatocellular carcinoma. 2024. doi: 10.12201/bmr.202412.00033

    shen pei cheng. Overview of TCM non-drug therapy of chronic kidney disease. 2024. doi: 10.12201/bmr.202409.00054

    chenjianqiu. Research progress on photodynamic therapy and recurrent respiratory papillomatosis. 2024. doi: 10.12201/bmr.202410.00009

    Review on therapies of basic and adjuvant of diabetic foot ulcer. 2020. doi: 10.12201/bmr.202004.00003

    Liu Yanan, Zhan Ming, Han Fei. Research Progress and Prospects of Finerenone in the Treatment of Diabetic Nephropathy. 2024. doi: 10.12201/bmr.202410.00033

    ZHANG Yi, Yuan Ping. Progress of research on the treatment of tobacco dependence by external therapeutic methods of traditional Chinese medicine. 2024. doi: 10.12201/bmr.202411.00040

    LUAN Zhi-Yong. Research progress of stem cell therapy for Hirschsprung disease. 2024. doi: 10.12201/bmr.202410.00021

    zhanglei. Progress in the application of dexmedetomidine in anesthesia through nasal administration. 2024. doi: 10.12201/bmr.202409.00057

  • ID Submit time Number Download
    1 2024-09-24

    10.12201/bmr.202410.00068V1

    Download
  • Public  Anonymous  To author only

Get Citation

luan xiaoqing, jiang taotao, wang manxia. [title missed]. 2024. biomedRxiv.202410.00068

Article Metrics

  • Read: 922
  • Download: 2
  • Comment: 0

Email This Article

User name:
Email:*请输入正确邮箱
Code:*验证码错误